PetVivo Holdings, Inc. Profile

Industry
Medical - Devices
Sector
Healthcare
Number of Employees
25

PetVivo Holdings's Business Model

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include 17 therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

About PetVivo Holdings

Website: https://www.petvivo.com

CEO (Chief Executive Officer): Mr. John Lai

IPO date: 2014-09-08

Contact

Country: US

Address: 5251 Edina Industrial Boulevard

City: Minneapolis

State: MN

Phone: 952 405 6216

Zip Code: 55439

Other

CIK: 0001512922

ISIN: US7168174081

CUSIP: 716817408

Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.